Invention Grant
- Patent Title: Pharmaceutical composition of a papillomavirus inhibitor
-
Application No.: US14399354Application Date: 2013-05-07
-
Publication No.: US09670159B2Publication Date: 2017-06-06
- Inventor: Marta Blumenfeld , Delphine Compere , Patricia Francon , Michel Hutin
- Applicant: AVIRAGEN THERAPEUTICS, INC.
- Applicant Address: US GA Alpharetta
- Assignee: AVIRAGEN THERAPEUTICS, INC.
- Current Assignee: AVIRAGEN THERAPEUTICS, INC.
- Current Assignee Address: US GA Alpharetta
- Agency: Stites & Harbison, PLLC.
- Agent B. Aaron Schulman, Esq.
- Priority: FR1254186 20120507
- International Application: PCT/EP2013/059475 WO 20130507
- International Announcement: WO2013/167583 WO 20131114
- Main IPC: C07D211/34
- IPC: C07D211/34 ; A61K9/00 ; A61K47/26 ; A61K9/06 ; A61K31/4453 ; C07D295/135
Abstract:
The invention relates to a pharmaceutical composition including a compound of general formula (I) combined with a solvent and a viscosity-enhancing agent, as well as to the use thereof as a drug, in particular for treating and preventing infection with the papillomavirus, and to the method for preparing same.
Public/Granted literature
- US20150152051A1 PHARMACEUTICAL COMPOSITION OF A PAPILLOMAVIRUS INHIBITOR Public/Granted day:2015-06-04
Information query
